Linagliptin is contraindicated in patients with a history of a hypersensitivity reaction to linagliptin, such as urticaria, angioedema, or bronchial hyperreactivity.
Linagliptin should not be used in patients with Type 1 Diabetes Mellitus or for the treatment of diabetic ketoacidosis, as it is not effective in these settings.